AGTC reported $12.2 million in revenue in its second fiscal quarter compared with $652,000 in the same period of 2014, according to a press release. The increase was primarily due to amortization of upfront fees received under the company’s collaboration with Biogen.
Glaukos establishes direct sales organization, launches iStent inject in Australia
Glaukos has established a direct sales organization and launched the iStent inject trabecular micro-bypass stent in Australia, according to a press release. The iStent inject was approved by the Therapeutic Goods Administration. It is to be used with c…
Senate health committee passes Next Generation Researchers Act
The Senate health committee passed the Next Generation Researchers Act (S. 2014) with bipartisan support on Tuesday, which aims to increase opportunities for young researchers and attract them to the NIH. The full Senate will now consider the bill. “In order for America to out-innovate the rest of the world and create an economy built to last, we must protect and strengthen our investments in research, science and innovation. We can’t accomplish this without supporting and investing in the next generation of researchers,” Senator Tammy Baldwin, D-Wis., said in a press (Read more...)
Senate: Health care IT bill will ‘end unfair practices’ for patients, providers
The U.S. Senate Committee on Health, Education, Labor and Pensions unanimously recommended a measure designed to improve health care information technology.The purpose of the “Improving Health Information Techonology Act” (S. 2511) is to simplify information sharing among doctors and allow patients easier access to their own medical records. The bill focuses on the use of the electronic health record — a real-time digital version of a patient’s medical chart — to allow for central record keeping of a patient’s entire medical history, including medications prescribed, treatment plans, immunization records, allergies, (Read more...)
Glaukos Corporation to Release Fourth Quarter & Full Year 2015 Financial Results after Market Close on March 1
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release fourth quarter and full year 2015 financial results after the market close on Tuesday, March 1, 2016. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30 p.m.
PharmaPoint: Dry Eye Syndrome – Global Drug Forecast and Market Assessment 2015-2024 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/hc7wft/pharmapoint_dry) has announced the addition of the “PharmaPoint: Dry Eye Syndrome – Global Drug Forecast and Market Assessment to 2024” report to their off…